Recent studies have shown that, binding of TLR4 to endogenous or exogenous ligands (from viral or bacterial infection) activates downstream NF‐κB signalling, which enables microglial activation and induces the release of pro‐inflammatory cytokines. The gene discussed is NFKB1; the disease is bacterial infectious disease.